VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 116 filers reported holding VOYAGER THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $784,732 | +26.4% | 101,781 | 0.0% | 0.02% | +31.2% |
Q4 2022 | $620,864 | +3.0% | 101,781 | 0.0% | 0.02% | 0.0% |
Q3 2022 | $603,000 | +17.5% | 101,781 | +17.3% | 0.02% | +33.3% |
Q2 2022 | $513,000 | -22.4% | 86,781 | 0.0% | 0.01% | -7.7% |
Q1 2022 | $661,000 | +561.0% | 86,781 | +135.9% | 0.01% | +550.0% |
Q4 2021 | $100,000 | -79.1% | 36,781 | -79.8% | 0.00% | -77.8% |
Q3 2021 | $478,000 | -26.0% | 181,881 | +16.4% | 0.01% | -25.0% |
Q2 2021 | $646,000 | -48.1% | 156,300 | -40.9% | 0.01% | -47.8% |
Q1 2021 | $1,245,000 | +88.1% | 264,339 | +655.3% | 0.02% | +283.3% |
Q3 2018 | $662,000 | -51.6% | 35,000 | -50.0% | 0.01% | -57.1% |
Q2 2018 | $1,368,000 | +4.0% | 70,000 | 0.0% | 0.01% | 0.0% |
Q1 2018 | $1,315,000 | +13.2% | 70,000 | 0.0% | 0.01% | +7.7% |
Q4 2017 | $1,162,000 | -19.4% | 70,000 | 0.0% | 0.01% | -18.8% |
Q3 2017 | $1,441,000 | – | 70,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 6,391,176 | $60,077,000 | 50.34% |
ARMISTICE CAPITAL, LLC | 2,836,000 | $26,658,000 | 2.02% |
Casdin Capital, LLC | 1,128,075 | $10,604,000 | 1.81% |
BB BIOTECH AG | 2,865,841 | $26,939,000 | 0.86% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,284,697 | $12,076,000 | 0.81% |
Aevitas Wealth Management, Inc. | 48,300 | $454,000 | 0.46% |
GREAT POINT PARTNERS LLC | 365,132 | $3,432,000 | 0.43% |
Patriot Financial Group Insurance Agency, LLC | 61,320 | $576,000 | 0.38% |
HARBOURVEST PARTNERS LLC | 72,726 | $684,000 | 0.32% |
Birchview Capital, LP | 33,000 | $310,000 | 0.29% |